论文信息 - Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia. - 字舞流文

Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia.

T. Shanafelt | G. Dewald | N. Kay | D. Jelinek | G. Nowakowski | R. Tschumper | S. Schwager | G. Nowakowski

[1] Axel Benner,et al. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2] M. Caligiuri,et al. Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3] T. Shanafelt,et al. Frequency of Clonal Evolution by FISH in Untreated, Early Stage Patients with CLL: A Prospective, Longitudinal Study with Long Clinical Follow-Up. , 2005 .

[4] D. Oscier,et al. ZAP-70 by Flow Cytometry: Comparison of Methodologies, and with IgVH Mutational and ZAP-70 Methylation Status. , 2005 .

[5] Arthur Weiss,et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. , 2004, The New England journal of medicine.

[6] T. Shanafelt,et al. clinical practice for patients with CLL Prognosis at diagnosis : integrating molecular biologic insights into , 2003 .